Crohn’s disease, European approval for the first Jak inhibitor
The European Commission has approved upadacitinib as the first Jak inhibitor for the treatment of adult ...
Read moreThe European Commission has approved upadacitinib as the first Jak inhibitor for the treatment of adult ...
Read moreThe American AbbVie announces that the Committee for Medicinal Products for Human Use (CHMP) of the ...
Read moreThe exclusion diet, which is based on avoiding foods that could cause an alteration of the ...
Read moreThe San Raffaele hospital in Milan hosted the meeting "New frontiers in the pharmacological treatment of ...
Read moreThe Milanese hospital hosted "New frontiers in the pharmacological treatment of IBDs" organized by the healthcare ...
Read more© Ruetir 2023. All Rights Reserved.